Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Shailesh Dewasthaly"'
Autor:
Rajeka Lazarus, Benedicte Querton, Irena Corbic Ramljak, Shailesh Dewasthaly, Juan Carlos Jaramillo, Katrin Dubischar, Michael Krammer, Petronela Weisova, Romana Hochreiter, Susanne Eder-Lingelbach, Christian Taucher, Adam Finn, Claire Bethune, Marta Boffito, Marcin Bula, Fiona M Burns, Rebecca Clark, Dileep Dasyam, Simon Drysdale, Saul Faust, Effrossyni Gkrania-Klotsas, Christopher Green, Hana Hassanin, Paul Heath, Amardeep Heer, Toby Helliwell, Anil Hormis, Philip Kalra, Ed Moran, John Ndikum, Iain Page, David Price, Nick Probert, Mahadev Ramjee, Tommy Rampling, Harpal S Randeva, Stephen Ryder, John Steer, Emma Thompson, David Torku
Publikováno v:
2022, ' Immunogenicity and safety of an inactivated whole-virus COVID-19 vaccine (VLA2001) compared with the adenoviral vector vaccine ChAdOx1-S in adults in the UK (COV-COMPARE) : interim analysis of a randomised, controlled, phase 3, immunobridging trial ', The Lancet Infectious Diseases, vol. 22, no. 12, pp. 1716-1727 . https://doi.org/10.1016/S1473-3099(22)00502-3, https://doi.org/10.1016/S1473-3099(22)00502-3
BackgroundThe Valneva COVID-19 vaccine (VLA2001; Valneva Austria, Vienna, Austria) is an inactivated whole-virus, adjuvanted SARS-CoV-2 vaccine. We aimed to assess the safety and immunogenicity of primary vaccination with VLA2001 versus the ChAdOx1-S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27f65e657505d72fb360ce88922221cf
https://hdl.handle.net/1983/8151ad0f-2432-43b1-a576-b9932a00559e
https://hdl.handle.net/1983/8151ad0f-2432-43b1-a576-b9932a00559e
Autor:
Jakob P. Cramer, Robert Steffen, Herbert L. DuPont, Kerstin Westritschnig, Ron H Behrens, Zhi-Dong Jiang, Prabhugaunker Ramdas, Santanu Chatterjee, Shailesh Dewasthaly, Gerd D. Burchard, Ute Schwarz, Tomas Jelinek
Publikováno v:
Journal of Travel Medicine. 20:374-379
Background A patch vaccine containing heat-labile toxin (LT) from enterotoxigenic Escherichia coli (ETEC) has demonstrated to be beneficial in reducing the rate and severity of travelers' diarrhea in Latin America. To evaluate the efficacy of this tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4281f3da8297f9f2447acab6a3ac410
https://doi.org/10.1111/jtm.12064
https://doi.org/10.1111/jtm.12064
Autor:
Robert Putnak, Martin Spruth, Shailesh Dewasthaly, Montip Gettayacamin, Alessandra Formica, Christoph Klade, Yvonne Van Gessel, Anchalee Tungtaeng, Somporn Krasaesub, Bruno Cena
Publikováno v:
Vaccine. 29:5925-5931
Immune sera from volunteers vaccinated in a blinded Phase 3 clinical trial with JE-VAX(®) and a new Japanese encephalitis virus (JEV) vaccine (IC51 or IXIARO), were tested for the ability to protect mice against lethal JEV challenge. Sera from IXIAR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa1bd8879ea084abfd9a189435eac9bd
https://doi.org/10.1016/j.vaccine.2011.06.062
https://doi.org/10.1016/j.vaccine.2011.06.062
Autor:
Shailesh Dewasthaly, Gabriele Wölfl, Erich Tauber, Christoph Klade, Elisabeth Schuller, A. Kaltenböck
Publikováno v:
Vaccine. 27:2188-2193
The standard administration of the investigational Japanese encephalitis vaccine IC51 is 2 doses of 6 microg with a 28-day interval. This study investigated the immunogenicity of a single-immunization, high-dose regimen (1 x 12 microg) compared to th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28f081839db4fa89a7d251e7fcef993e
https://doi.org/10.1016/j.vaccine.2008.12.062
https://doi.org/10.1016/j.vaccine.2008.12.062
Autor:
Erich Tauber, Shailesh Dewasthaly
Publikováno v:
bchm. 389:547-550
Japanese encephalitis causes serious health problems in countries in Southeast Asia, where the causative virus is endemic. Whereas most adults living in this region have acquired immunity, children are at high risk of infection. Childhood mass immuni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2605fa65506756edac4bead9d5887f2
https://doi.org/10.1515/bc.2008.062
https://doi.org/10.1515/bc.2008.062
Autor:
Jakob P. Cramer, Shailesh Dewasthaly, Ron H Behrens, Herbert L. DuPont, Frank von Sonnenburg, Tomas Jelinek, Gregory M. Glenn, Darren Wilbraham, Mercedes Paredes-Paredes, Hilary Shaw, Donald M Stablein, Zhi-Dong Jiang, Thomas Weinke, David J Bell, Roberto Maxwell, Hermann L Enkerlin Pauwells, Edwin J. Asturias
Publikováno v:
The Lancet. Infectious diseases. 14(3)
Enterotoxigenic Escherichia coli (ETEC) is a major cause of travellers' diarrhoea. We investigated the efficacy and safety of a skin-patch vaccine containing the pathogen's heat-labile toxin (LT) in a population of travellers to Mexico and Guatemala.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a65775ecf2a98c566fa38509a471996f
https://pubmed.ncbi.nlm.nih.gov/24291167
https://pubmed.ncbi.nlm.nih.gov/24291167
Autor:
Elisabeth Schuller, Katrin Dubischar-Kastner, Zsuzsanna Müller, Anton Klingler, Shailesh Dewasthaly
Publikováno v:
Vaccine. 29(47)
Japanese encephalitis (JE) is the most common cause for viral encephalitis in Asia and can be effectively prevented by vaccination. IXIARO(®) is a Vero cell-derived, inactivated JE virus vaccine which has been licensed and distributed in the US, Eur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::358b41f38562ba13c6efba846ac180ad
https://pubmed.ncbi.nlm.nih.gov/21907747
https://pubmed.ncbi.nlm.nih.gov/21907747
Autor:
Wolfgang Schüler, Knut Hordnes, Beatrice M. Senn, Dieter Gelbmann, Shailesh Dewasthaly, Eszter Nagy, Birgit Noiges, Markus Hanner, Urban Lundberg, Alexander von Gabain, Jan Sinzinger, Tamás Henics, Helga Masoud, Zehra Visram, Duc Bui Minh, Paul Sevelda, Christina Neubauer, Andreas Meinke
Publikováno v:
Vaccine. 28(43)
Group B streptococcus is one of the most important pathogens in neonates, and causes invasive infections in non-pregnant adults with underlying diseases. Applying a genomic approach that relies on human antibodies we identified antigenic GBS proteins
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96ec149d41723f7ba05608c2071ede2d
https://pubmed.ncbi.nlm.nih.gov/20732466
https://pubmed.ncbi.nlm.nih.gov/20732466
Autor:
Shailesh Dewasthaly, Bernd Jilma, Christa Firbas, Christoph Klade, Erich Tauber, Herwig Kollaritsch, Sabine Schranz, E Jong, M Korinek, A Klingler, Pamela Rendi-Wagner
Publikováno v:
Lancet (London, England). 370(9602)
Summary Background Japanese encephalitis virus (JEV) is the leading cause of viral encephalitis in southeast Asia. Although no treatment is currently available, vaccination effectively prevents the disease. In a non-inferiority study, we aimed to com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::073feac1c6dff75773ab323f4d50ef1b
https://pubmed.ncbi.nlm.nih.gov/19094823
https://pubmed.ncbi.nlm.nih.gov/19094823